NFE2L2 and fatty liver disease: Of note, it has also been reported that the activation of the Keap1/Nrf2 signaling pathway to maintain a redox status mediates lipid metabolism-related genes (SREBP-1c and PPARα) to reduce hepatic steatosis in an HFD-induced obese animal model [23].